Researchers at the West Virginia University’s Rockefeller Neuroscience Institute have successfully performed a phase II trial using focused ultrasound to treat a patient with early onset Alzheimer’s disease. This is exciting news and holds promise for future treatments. The complete article can be accessed by clicking here.